Insiders · Profile

Anders Jack

Chief Financial Officer at Revolution Medicines. Filing since 6 Oct 2020. CIK 0001800668

Company

Date

Role

Action

Shares

Amount

Of holding

RVMD Revolution Medicines, Inc.

16 Sep 2026

Chief Financial Officer

Sold on a plan

4,053

$807.51K

3.3%

RVMD Revolution Medicines, Inc.

24 Jun 2026

Chief Financial Officer

Sold on a plan

20,000

$3.37M

14.0%

RVMD Revolution Medicines, Inc.

16 Jun 2026

Chief Financial Officer

Sold on a plan

2,722

$424.96K

2.2%

RVMD Revolution Medicines, Inc.

17 Mar 2026

Chief Financial Officer

Sold on a plan

2,753

$273.87K

2.1%

RVMD Revolution Medicines, Inc.

7 Jan 2026

Chief Financial Officer

Sold on a plan

10,000

$980.00K

8.5%

RVMD Revolution Medicines, Inc.

16 Dec 2025

Chief Financial Officer

Sold on a plan

3,104

$239.29K

2.8%

RVMD Revolution Medicines, Inc.

25 Nov 2025

Chief Financial Officer

Sold on a plan

5,418

$400.93K

4.7%

RVMD Revolution Medicines, Inc.

11 Nov 2025

Chief Financial Officer

Sold on a plan

10,000

$640.00K

8.3%

RVMD Revolution Medicines, Inc.

16 Sep 2025

Chief Financial Officer

Sold on a plan

2,320

$106.31K

2.0%

RVMD Revolution Medicines, Inc.

3 Sep 2025

Chief Financial Officer

Sold on a plan

5,238

$210.43K

4.4%

RVMD Revolution Medicines, Inc.

2 Sep 2025

Chief Financial Officer

Sold on a plan

4,762

$190.56K

4.0%

RVMD Revolution Medicines, Inc.

16 Jun 2025

Chief Financial Officer

Sold on a plan

2,170

$86.43K

1.9%

RVMD Revolution Medicines, Inc.

17 Mar 2025

Chief Financial Officer

Sold on a plan

1,864

$72.77K

1.6%

RVMD Revolution Medicines, Inc.

16 Dec 2024

Chief Financial Officer

Sold on a plan

2,635

$119.64K

2.7%

RVMD Revolution Medicines, Inc.

11 Oct 2024

Chief Financial Officer

Sold on a plan

10,000

$502.98K

9.2%

RVMD Revolution Medicines, Inc.

16 Sep 2024

Chief Financial Officer

Sold on a plan

2,244

$99.15K

2.2%

RVMD Revolution Medicines, Inc.

17 Jun 2024

Chief Financial Officer

Sold on a plan

1,893

$70.77K

1.8%

RVMD Revolution Medicines, Inc.

3 May 2024

Chief Financial Officer

Sold on a plan

10,000

$400.26K

8.9%

RVMD Revolution Medicines, Inc.

18 Mar 2024

Chief Financial Officer

Sold on a plan

1,261

$39.83K

1.2%

RVMD Revolution Medicines, Inc.

18 Dec 2023

Chief Financial Officer

Sold on a plan

1,775

$45.98K

2.3%

RVMD Revolution Medicines, Inc.

18 Sep 2023

Chief Financial Officer

Sold at will

1,427

$44.68K

2.6%

RVMD Revolution Medicines, Inc.

1 Sep 2023

Chief Financial Officer

Sold on a plan

20,000

$701.09K

26.6%

RVMD Revolution Medicines, Inc.

20 Jun 2023

Chief Financial Officer

Sold at will

1,249

$31.09K

2.2%

RVMD Revolution Medicines, Inc.

17 Mar 2023

Chief Financial Officer

Sold at will

665

$14.48K

1.2%

RVMD Revolution Medicines, Inc.

19 Dec 2022

Chief Financial Officer

Sold, plan not stated

658

$15.09K

2.2%

RVMD Revolution Medicines, Inc.

19 Sep 2022

Chief Financial Officer

Sold, plan not stated

449

$8.55K

1.5%

RVMD Revolution Medicines, Inc.

17 Jun 2022

See Remarks

Sold, plan not stated

406

$7.21K

2.0%

RVMD Revolution Medicines, Inc.

17 Mar 2022

See Remarks

Sold, plan not stated

159

$2.96K

0.8%

RVMD Revolution Medicines, Inc.

17 Dec 2021

See Remarks

Sold, plan not stated

170

$4.15K

2.0%

RVMD Revolution Medicines, Inc.

17 Sep 2021

See Remarks

Sold, plan not stated

166

$4.98K

2.0%

RVMD Revolution Medicines, Inc.

17 Jun 2021

See Remarks

Sold, plan not stated

160

$5.46K

1.9%

RVMD Revolution Medicines, Inc.

13 Oct 2020

See Remarks

Sold, plan not stated

10,000

$440.00K

100%

RVMD Revolution Medicines, Inc.

6 Oct 2020

See Remarks

Sold, plan not stated

10,000

$400.00K

100%

33 decisions on file.